Clinical Trials Browser

Phase 1/2 × Active not recruiting × Megestrol Acetate × Clear all

NCT05538897 2026-05-13

Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers

Phase 1/2 Active not recruiting

FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma